Anti-angiogenic cancer vaccinations – a promising future for cancer immunotherapy

In this video, Samuel C. Wagner, President and CEO of Batu Biologics, discusses Facciponte’s study of a TEM-1 DNA vaccination’s efficacy as a cancer therapeutic and the affect of the vaccination on healthy angiogenesis processes in the body.

[video_left][video_frame]
[iframe url=”http://www.youtube.com/embed/IK7LDuxUUJo” width=”572″ height=”312″]
[/video_frame]

Watch the video